Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 205

1.

Is Vancouver Canada's supervised injection facility cost-saving?

Pinkerton SD.

Addiction. 2010 Aug;105(8):1429-36. doi: 10.1111/j.1360-0443.2010.02977.x.

PMID:
20653622
2.

A cost-benefit and cost-effectiveness analysis of Vancouver's supervised injection facility.

Andresen MA, Boyd N.

Int J Drug Policy. 2010 Jan;21(1):70-6. doi: 10.1016/j.drugpo.2009.03.004. Epub 2009 May 6.

PMID:
19423324
3.

The cost-effectiveness of Vancouver's supervised injection facility.

Bayoumi AM, Zaric GS.

CMAJ. 2008 Nov 18;179(11):1143-51. doi: 10.1503/cmaj.080808.

4.

Vancouver's supervised injection facility challenges Canada's drug laws.

Dooling K, Rachlis M.

CMAJ. 2010 Sep 21;182(13):1440-4. doi: 10.1503/cmaj.100032. Epub 2010 Aug 30. No abstract available.

5.

How many HIV infections are prevented by Vancouver Canada's supervised injection facility?

Pinkerton SD.

Int J Drug Policy. 2011 May;22(3):179-83. doi: 10.1016/j.drugpo.2011.03.003. Epub 2011 Mar 29.

PMID:
21450450
6.

Estimating the cost-effectiveness of needle-syringe programs in Australia.

Kwon JA, Anderson J, Kerr CC, Thein HH, Zhang L, Iversen J, Dore GJ, Kaldor JM, Law MG, Maher L, Wilson DP.

AIDS. 2012 Nov 13;26(17):2201-10. doi: 10.1097/QAD.0b013e3283578b5d.

PMID:
22914579
7.

Changes in injecting practices associated with the use of a medically supervised safer injection facility.

Stoltz JA, Wood E, Small W, Li K, Tyndall M, Montaner J, Kerr T.

J Public Health (Oxf). 2007 Mar;29(1):35-9. Epub 2007 Jan 17.

PMID:
17229788
8.

Evaluating Vancouver's supervised injection facility: data and dollars, symbols and ethics.

Des Jarlais DC, Arasteh K, Hagan H.

CMAJ. 2008 Nov 18;179(11):1105-6. doi: 10.1503/cmaj.081678. English, French. No abstract available.

9.

Syringe exchange in the United States: a national level economic evaluation of hypothetical increases in investment.

Nguyen TQ, Weir BW, Des Jarlais DC, Pinkerton SD, Holtgrave DR.

AIDS Behav. 2014 Nov;18(11):2144-55. doi: 10.1007/s10461-014-0789-9.

10.

Cost-effectiveness of syringe exchange as an HIV prevention strategy.

Laufer FN.

J Acquir Immune Defic Syndr. 2001 Nov 1;28(3):273-8.

PMID:
11694836
11.

Needle exchange programs: an economic evaluation of a local experience.

Gold M, Gafni A, Nelligan P, Millson P.

CMAJ. 1997 Aug 1;157(3):255-62.

12.

Syringe sharing and HIV incidence among injection drug users and increased access to sterile syringes.

Kerr T, Small W, Buchner C, Zhang R, Li K, Montaner J, Wood E.

Am J Public Health. 2010 Aug;100(8):1449-53. doi: 10.2105/AJPH.2009.178467. Epub 2010 Jun 17.

13.

An economic analysis of needle exchange and pharmacy-based programs to increase sterile syringe availability for injection drug users.

Lurie P, Gorsky R, Jones TS, Shomphe L.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18 Suppl 1:S126-32.

PMID:
9663635
14.

A cost-benefit/cost-effectiveness analysis of proposed supervised injection facilities in Ottawa, Canada.

Jozaghi E, Reid AA, Andresen MA, Juneau A.

Subst Abuse Treat Prev Policy. 2014 Aug 4;9:31. doi: 10.1186/1747-597X-9-31.

15.

Needle exchange programs and drug infection behavior.

DeSimone J.

J Policy Anal Manage. 2005 Summer;24(3):559-77.

PMID:
15973795
16.

Cost and cost-effectiveness of increasing access to sterile syringes and needles as an HIV prevention intervention in the United States.

Holtgrave DR, Pinkerton SD, Jones TS, Lurie P, Vlahov D.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18 Suppl 1:S133-8.

PMID:
9663636
17.

[Evaluation of a pilot study on needle and syringe exchange program among injecting drug users in a community in Guangdong, China].

Lin P, Fan ZF, Yang F, Wu ZY, Wang Y, Liu YY, Ming ZQ, Li WJ, Luo W, Fu XB, Mai XR, Xu RH, Feng WY, He Q.

Zhonghua Yu Fang Yi Xue Za Zhi. 2004 Sep;38(5):305-8. Chinese.

PMID:
15498241
18.
19.

Needle exchange and the HIV epidemic in Vancouver: lessons learned from 15 years of research.

Hyshka E, Strathdee S, Wood E, Kerr T.

Int J Drug Policy. 2012 Jul;23(4):261-70. doi: 10.1016/j.drugpo.2012.03.006. Epub 2012 May 11. Review.

20.

Use of an illegal syringe exchange and injection-related risk behaviors among street-recruited injection drug users in Oakland, California, 1992 to 1995.

Bluthenthal RN, Kral AH, Erringer EA, Edlin BR.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Aug 15;18(5):505-11.

PMID:
9715848

Supplemental Content

Support Center